IVA Stock Analysis: Buy, Sell, or Hold?
IVA - Inventiva S.A. American Depository Shares
$4.48
-0.14 (-3.03%)
▼
5d:
+0.45%
30d:
+21.41%
90d:
-12.67%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Sep 25, 2026
Get Alerted When IVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: IVA shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: IVA shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: IVA is currently trading at $4.48, which is considered slightly high relative to its 30-day fair value range of $3.78 to $4.62.
Technical Outlook: Technically, IVA is in a strong downtrend. Immediate support is located at $4.31, while resistance sits at $4.71. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: IVA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $15.11 (+237.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IVA is in a strong downtrend. Immediate support is located at $4.31, while resistance sits at $4.71. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: IVA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $15.11 (+237.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$3.78 -
$4.62
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.7%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.0%)
- BULLISH: Trading 237.4% below Wall St target ($15.11)
Trading Range Analysis
30-Day Trading Range
$3.78 -
$4.62
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$4.31
Resistance Level
$4.71
Current Trend
Strong Downtrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.38
Wall Street Target
$15.11
(+237.4%)
Revenue Growth (YoY)
-89.9%
Share & Embed Analysis
Last updated: August 03, 2026 1:47 AM ET
Data refreshes hourly during market hours. Next update: 2:47 AM
Data refreshes hourly during market hours. Next update: 2:47 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IVA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 50 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$834 | 58 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$267 | 60 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 56 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$33 | 58 HOLD |
